This collaboration will leverage a Medtronic-developed technology platform, supported by clinical insight from Apollo.
The collaboration seeks improved accessibility, outcomes, affordability, operational ease, and environmental protection whilst providing hemodialysis services to ESRD patients requiring RRT.
Medtronic intends to develop and manufacture key components of this system in India, with an investment of more than 150 crore rupees (USUSD 25M).
For the first time, Medtronic is establishing an India R and D team that will focus on design, development and manufacturing of key components of the system in India. The commercial launch of the product is slated for 2016.
Prathap C Reddy, Chairman, Apollo Hospitals said, "Our partnership with Medtronic will help in fulfilling our vision of delivering better clinical outcomes through bench-to-bedside innovation.
"This alliance reinforces Apollo's commitment to research-driven healthcare. We are undertaking this landmark initiative to explore opportunities in dialysis solutions to address a critical need with the right, yet affordable treatment as part of our legacy of providing clinical excellence. This collaboration is a further symbol of Apollo's commitment to having a share in everyone's good health by touching lives," Reddy said.
--IBNS (Posted on 11-10-2013)